BNET Industries

Last Fiscal Year Sales:$10.0B
  • Public
  • JP
Dow Jones Description

Takeda promises better living through chemicals. Founded in 1781 and headquartered in Osaka, Japan, Takeda Pharmaceutical Company Limited is Japan's largest drug maker. The company, besides making pharmaceutical products, also offers vitamins, food additives, and some chemicals. It is developing drugs for a range of diseases and conditions. The company has annual revenues of about $10.4 billion and employs about 14,500 people. It recently announced plans to acquire Syrrx in order to start an R&D operation in the US.

Chairman & CEO
Kunio Takeda
Number of Employees 15,717
Contact Information

1-1 Doshomachi 4-Chome

Chuo-Ku

Osaka 540 8645

www.takeda.com

(81) 6 6204 2111

NAICS Code Frozen Fruit, Juice, and Vegetable Manufacturing: 311411

Recent Events

  • Sanofi May Launch Venture Fund

    11/12/09 - Merger / Acquisition - View Story

  • Domain Therapeutics announces successful completion of the first milestone in its Research Agreement with Takeda...

    11/04/09 - Joint Venture / Alliance - View Story

  • Japan co Takeda Pharma licenses US co Amylin for obesity drug

    11/04/09 - Licensing / Contract - View Story

  • Market Report -- In Play AMLN

    11/02/09 - Joint Venture / Alliance - View Story

  • Pharmaceuticals see proposed health care legislation as mixed bag

    11/07/09 - Joint Venture / Alliance - View Story

  • Takeda Pharma H1 Profit Soars; Updates FY09 Forecast - Update

    10/30/09 - Stock Split / Dividend - View Story

  • Strong Yen Hits Drug Firms

    11/01/09 - Financial Announcement - View Story

  • Week of Oct. 12, 2009: GSK and Prosensa Form Pact; Cardiokine Appoints CEO; More...

    10/14/09 - Mgmt. Change Entering - Vice President - View Story

  • Takeda San Francisco Enters Into A Sponsored Research Agreement With University of California, San Francisco...

    9/22/09 - Joint Venture / Alliance - View Story

  • Sepracor vows to stay in Mass.

    9/04/09 - Licensing / Contract - View Story

  • Dainippon Agrees to Buy Sepracor

    9/04/09 - Merger / Acquisition - View Story

  • Takeda to start key diabetes drug trial in Sept

    8/28/09 - Bond / Stock Rating - View Story

  • Alnylam Q2 net loss widens

    8/11/09 - Financial Announcement - View Story

News & Analysis

takeda pharmaceutical company ltd. - All News and Analysis

Decision Makers

Name (plus bio) Position
Alan Mackenzie President
Hiroshi Ohtsuki President, Consumer Healthcare
Yasuchika Hasegawa President & COO
Hiroshi Akimoto Managing Director
Hiroshi Shinha General Manager, Legal Dept
Hiroshi Takahara General Manager, Finance & Accounting Dept
Kazuaki Ikeya General Manager, Strategic Product Planning
Kiyoshi Kitazawa General Manager, Pharmaceutical Development Division
Makoto Yamaoka Managing Director & General Manager, Pharmaceutical Marketing Division
Naohisa Takeda General Manager, Europe & Asia
Toyoji Yoshida General Manager, Corp Communs Dept
Tsutomu Miura General Manager, Ethical Products Marketing Dept
Yasuhiko Yamanaka General Manager, Corp Strategy & Planning
Graeme Martin
Jacques Bertran De Balanda
Masahiro Fujimaki
Nick Manusos
Yuji Iizawa

Board of Directors

Name (plus bio) Position
Kunio Takeda Chairman & CEO
James L. Tyree Board of Directors
Takshi Soda Board of Directors

Organization Position Status
Takeda Pharmaceutical Company Limited Chairman & CEO Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited President Current

Organization Position Status
Takeda Pharmaceutical Company Limited President, Consumer Healthcare Current

Organization Position Status
Takeda Pharmaceutical Company Limited President & COO Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited Managing Director Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Legal Dept Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Finance & Accounting Dept Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Strategic Product Planning Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Pharmaceutical Development Division Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited Managing Director & General Manager, Pharmaceutical Marketing Division Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Europe & Asia Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Corp Communs Dept Current
Takeda Pharmaceutical Company Limited Board of Directors Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Ethical Products Marketing Dept Current

Organization Position Status
Takeda Pharmaceutical Company Limited General Manager, Corp Strategy & Planning Current

Array

Organization Position Status
Takeda Research Investment, Inc. President & CEO Current
Roche Bioscience Current
Takeda Pharmaceutical Company Limited Current
University College Doctorate Former
University of Bath Bachelor of Science Degree In Pharmacology Former

Jacques is head of our Paris office corporate group. He specialises in corporate M&A work and in EU competition and merger issues, working also out of the firm's Brussels office. His client base includes a wide range of European, Japanese, American and global blue-chip companies including TUI, Takeda Pharmaceutical, Total, Belgacom, M-real and Toyota Motor Corporation.

Organization Position Status
Herbet Smith LLP Pragmatic Transactional Adviser Current
Takeda Pharmaceutical Company Limited Current

Masahiro Fujimaki serves as the Executive Vice President of Takeda Pharmaceuticals North America (TPNA), Inc. In this role, Fujimaki is responsible for supervising and directing all of the business affairs of TPNA in accordance with the Board of Directors' corporate directives. Specifically, in cooperation with TPNA's parent company, Takeda Pharmaceutical Company Limited (TPC), Fujimaki is responsible for overseeing the development and operations of the corporate infrastructure of TPNA. In addition, he takes an executive role in the development of corporate policies relating to all internal departments and functions. Fujimaki has worked for more than 18 years with TPC. During that time, Fujimaki held progressively responsible managerial positions and has gained considerable experience in the international management and marketing of Takeda's pharmaceutical products. His Takeda experience includes several successful roles in the Domestic Marketing and Sales Division, and Corporate Strategy and Planning Department. More recently, Fujimaki worked as a manager of Division of Americas in charge of two affiliates in the U.S. as well as licensee business in North and South American countries. Fujimaki earned a bachelor's degree in economics from Keio University of Tokyo.

Organization Position Status
Takeda Pharmaceutical Company Limited Current
Tpc Former
University of Tokyo Bachelor's Degree In Economics Former

Nick Manusos serves as Vice President of Business Development at Takeda Pharmaceuticals North America (TPNA), Inc. Manusos joined TPNA in July of 2006. His responsibilities include directing Takeda's efforts in partnerships, licensing and alliance management in North America as well as for global Takeda business. Prior to joining TPNA, Manusos worked at TAP Pharmaceutical Products Inc. for six years. TAP is a joint venture of Japan-based Takeda Pharmaceutical Company Limited (TPC) and Abbott Laboratories. He joined TAP as licensing director in 2000. In that role, Manusos oversaw or personally executed domestic and international research collaborations, technology and device licensing and co-promotion and pharmaceutical compound licensing. Manusos was promoted to vice president of licensing and business development in April of 2004 and was responsible for leading the licensing and business development team and the alliance management team in building TAP's portfolio of products. Manusos joined the Ross Products division of Abbott in 1983. He held various business and operations management positions at Abbott, including business director of Global Generics and Custom Pharma within Abbott's Specialty Products division, and general manager of Abbott Animal Health. He currently sits on the executive board of the Opera Theatre North. Manusos earned a bachelor of business administration degree in operations management from the University of Wisconsin - Whitewater and a master's degree in business administration at the Kellogg School of Management.

Organization Position Status
Abbott Animal Health General Manager Current
Takeda Pharmaceutical Company Limited Current
Abbott Laboratories Current
TAP Pharmaceutical Products Inc. Vice President Former
Tap Inc Director Former
Kellogg School of Management at Northwestern University Master's Degree In Business Administration Former
University of Wisconsin-Whitewater Business Administration Degree In Operations Management Former

Organization Position Status
Takeda Pharmaceutical Company Limited Current
Massachusetts Institute of Technology doctorate from Nagoya City University Former

James Tyree is senior vice president, Pharmaceutical Operations Tyree first joined Abbott from 1978 until 1979 as a business analyst for a year. He rejoined the company in June 1997 and has been in various management positions including divisional vice president and general manager for Abbott's international division in Japan. He recently served as vice president, global licensing/new business development in the Pharmaceutical Products Division. He assumed his current role in 2006. Prior to re-joining Abbott in 1997, Tyree was president of Sugen Inc., a biotechnology start-up company and held various leadership positions at other pharmaceutical companies. He serves on the board of directors for TAP Pharmaceuticals, a joint venture between Abbott and Takeda Pharmaceutical Company Limited. He is a member of the advisory boards of the Polsky Center of Entrepreneurship at the University of Chicago and the Kellogg Center for Biotechnology at Northwestern University. He is a member of Richard M. Daley's Chicago Mayor's Council of Technology Advisors. Formerly chairman, he is also chairman of the board of directors of the Illinois Biotechnology Industry Organization. He earned bachelor's degrees in psychology and forensic studies and a master's degree in business administration from Indiana University.

Organization Position Status
Northwestern University Member Current
University of Chicago Member Current
Kellogg Company Member Current
Takeda Pharmaceutical Company Limited Board of Directors Current
Indiana University Master's Degree In Business Administration Former

Organization Position Status
Takeda Pharmaceutical Company Limited Board of Directors Current

Executive News

  • UPDATE 1-Japan's Takeda to buy IDM Pharma in cancer drug push

    Forbes.com - 5/18/09 - View Story

  • UPDATE 1-Japan's Takeda to buy IDM Pharma in cancer drug push

    Reuters - 5/18/09 - View Story

  • Takeda Posts 34% Profit Drop

    The Wall Street Journal Interactive Edition - 5/11/09 - View Story

advertisement
advertisement
Click Here